Surgical Care (SCAI) Posts Q1 Loss, Sales Beat Views

Surgical Care (NASDAQ: SCAI) reported Q1 EPS of ($0.24), riven by $15.6 million of one-time expenses related to a secondary stock offering and a debt refinancing completed in the first quarter, which does not compare to the analyst estimate of $0.37. Revenue for the quarter came in at $234.1 million versus the consensus estimate of $223.9 million.

For 2015, the Company reiterates its original 2015 guidance, which it initially disclosed in January. The Company continues to expect 2015 Adjusted EBITDA less NCI growth to be in the range of 8% to 11%.

"Patient care is our first priority, and our teammates and physician partners continue to achieve strong clinical quality and patient satisfaction results. From a strategic standpoint, we continue to partner with outstanding health systems and physician groups, including adding ten new facilities since the beginning of the year, and our development pipeline remains strong," said Andrew Hayek, President & CEO. "From a financial standpoint, we are on track with our original guidance, and we are on track to achieve a seventh consecutive year of approximately ten percent growth in adjusted EBITDA less NCI, reflecting the outstanding work of our teammates across the country."

For earnings history and earnings-related data on Surgical Care (SCAI) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Swarmer chairman outlines expansion strategy beyond drone software
• Nvidia pitches Vera CPU to Chinese clients with August delivery target